L H Lindner Selected Research

L H Lindner Research Topics

10	Neoplasms (Cancer) 06/2019 - 04/2004
6	Hyperthermia 06/2019 - 09/2003
6	Sarcoma (Soft Tissue Sarcoma) 06/2019 - 05/2014
2	Clear Cell Sarcoma 01/2019 - 12/2017
1	Fatigue 01/2018
1	Nausea 01/2018
1	Vomiting 01/2018
1	Alveolar Soft Part Sarcoma 01/2018
1	Disease Progression 05/2014
1	Hemolytic Anemia 10/2013
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 10/2013
1	Hairy Cell Leukemia 10/2013
1	Pancytopenia 10/2013
1	Thrombotic Thrombocytopenic Purpura 10/2013
1	Hemolytic-Uremic Syndrome 10/2013
1	Splenomegaly 10/2013
1	Thrombocytopenia (Thrombopenia) 10/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2010
1	Renal Insufficiency (Renal Failure) 11/2008
1	Ovarian Neoplasms (Ovarian Cancer) 10/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2006

3	AnthracyclinesIBA 06/2019 - 10/2006
3	CrizotinibIBA 01/2019 - 12/2017
2	Ifosfamide FDA LinkGeneric 06/2019 - 07/2016
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017
1	pazopanib FDA Link 12/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2016
1	thiamine triphosphorate (TTP)IBA 10/2013
1	purineIBA 10/2013
1	Coloring Agents (Dyes)IBA 10/2013
1	erucylphosphohomocholine ErPC3IBA 04/2010
1	Arabinofuranosyluracil (Ara U)IBA 11/2008
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2008
1	PlatinumIBA 10/2006
1	Taxoids (Taxanes)IBA 10/2006
1	Liposomes (Liposome)IBA 09/2003

5	Drug Therapy (Chemotherapy) 06/2019 - 04/2004
4	Radiotherapy 06/2019 - 04/2004
4	Therapeutics 05/2014 - 09/2005
2	Combined Modality Therapy 06/2019 - 05/2014
1	Catheters 01/2019
1	Neoadjuvant Therapy 05/2014
1	Plasma Exchange 10/2013
1	Aftercare (After-Treatment) 11/2008
1	Induced Hyperthermia (Thermotherapy) 04/2004